|

Sodium Thiosulfate Clinical Trials

2 actively recruiting trials across 2 locations

▼ -1 trial since May 2026

Also known as: Cyanide Antidote Package, Disodium Thiosulfate, S-Hydril, Sodium Hyposulfate, Sodium Thiosulfate Pentahydrate +5 more

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

  • National Cancer Institute (NCI)1
  • Children's Oncology Group1

Indications

  • Cancer2
  • Atypical Mesothelial Proliferation1
  • Childhood Medulloblastoma1
  • Peritoneal Mesothelioma1
  • Gastrointestinal Cancer1

Birmingham, Alabama1 trial

A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss

Children's Hospital of Alabama

Phase 3

Bethesda, Maryland1 trial

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

National Institutes of Health Clinical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.